Ho RH - Search Results

1

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.

Ho RH, Choi L, Lee W, Mayo G, Schwarz UI, Tirona RG, Bailey DG, Stein CM, Kim RB. Ho RH, et al. Pharmacogenet Genomics. 2007 Aug;17(8):647-56. doi: 10.1097/FPC.0b013e3280ef698f. Pharmacogenet Genomics. 2007. PMID: 17622941 Free PMC article. Clinical Trial.

2

Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition.

Ho RH, Leake BF, Roberts RL, Lee W, Kim RB. Ho RH, et al. J Biol Chem. 2004 Feb 20;279(8):7213-22. doi: 10.1074/jbc.M305782200. Epub 2003 Dec 2. J Biol Chem. 2004. PMID: 14660639 Free article.

3

Transporters and drug therapy: implications for drug disposition and disease.

Ho RH, Kim RB. Ho RH, et al. Clin Pharmacol Ther. 2005 Sep;78(3):260-77. doi: 10.1016/j.clpt.2005.05.011. Clin Pharmacol Ther. 2005. PMID: 16153397 Review.

4

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. Ho RH, et al. Gastroenterology. 2006 May;130(6):1793-806. doi: 10.1053/j.gastro.2006.02.034. Epub 2006 Mar 6. Gastroenterology. 2006. PMID: 16697742

5

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe.

Urquhart BL, Ware JA, Tirona RG, Ho RH, Leake BF, Schwarz UI, Zaher H, Palandra J, Gregor JC, Dresser GK, Kim RB. Urquhart BL, et al. Among authors: ho rh. Pharmacogenet Genomics. 2008 May;18(5):439-48. doi: 10.1097/FPC.0b013e3282f974dc. Pharmacogenet Genomics. 2008. PMID: 18408567 Free PMC article.

6

Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.

Meyer zu Schwabedissen HE, Tirona RG, Yip CS, Ho RH, Kim RB. Meyer zu Schwabedissen HE, et al. Among authors: ho rh. Cancer Res. 2008 Nov 15;68(22):9338-47. doi: 10.1158/0008-5472.CAN-08-0265. Cancer Res. 2008. PMID: 19010908 Free PMC article.

7

Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability.

Ho RH, Leake BF, Kilkenny DM, Meyer Zu Schwabedissen HE, Glaeser H, Kroetz DL, Kim RB. Ho RH, et al. Pharmacogenet Genomics. 2010 Jan;20(1):45-57. doi: 10.1097/FPC.0b013e3283349eb0. Pharmacogenet Genomics. 2010. PMID: 20010382 Free PMC article.

8

Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.

Schwarz UI, Meyer zu Schwabedissen HE, Tirona RG, Suzuki A, Leake BF, Mokrab Y, Mizuguchi K, Ho RH, Kim RB. Schwarz UI, et al. Among authors: ho rh. Pharmacogenet Genomics. 2011 Mar;21(3):103-14. doi: 10.1097/FPC.0b013e328342f5b1. Pharmacogenet Genomics. 2011. PMID: 21278621 Free PMC article.

9

Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).

Ho RH, Leake BF, Urquhart BL, Gregor JC, Dawson PA, Kim RB. Ho RH, et al. J Gastroenterol Hepatol. 2011 Dec;26(12):1740-8. doi: 10.1111/j.1440-1746.2011.06805.x. J Gastroenterol Hepatol. 2011. PMID: 21649730 Free PMC article.

10

Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.

DeGorter MK, Ho RH, Leake BF, Tirona RG, Kim RB. DeGorter MK, et al. Among authors: ho rh. Mol Pharm. 2012 Apr 2;9(4):986-95. doi: 10.1021/mp200629s. Epub 2012 Mar 6. Mol Pharm. 2012. PMID: 22352740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters